RNL BIO Co. Ltd

IBT PR Center > RNL BIO Co. Ltd

Pharmaceutical

A Breakthrough in Cancer Therapy Through RNL BIO's Adult Stem Cell Technology

Aug 09, 2010 9:00PM

The leading biopharmaceutical company specialized in adult stem cell therapeutics, RNL BIO Co., Ltd, (Korean Stock Exchange, 003190, www.rnl.co.kr) announced on July 27th...

Pharmaceutical, Hospitals, Biotechnology, California

About IBT PR Center

The IBTAnnouncement Service helps investors discover the latest information reported by companies in which they are invested, including changes in voting rights, net asset values, and more.

Popular Tags

Wells Fargo & Company (14)
Contest (69)
Product/Service (4952)
Retail (1703)
Construction & Property (924)
Illinois (1059)
Automotive (390)
Food/Beverage (708)
Internet (2659)
Homeland Security (277)
Other Technology (1207)
United States (10505)
Ready Solar Inc. (0)
Aéroports de Paris (6)
Finance (3921)
Energy (1171)